Alarmins: awaiting a clinical response
Top Cited Papers
Open Access
- 1 August 2012
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 122 (8) , 2711-2719
- https://doi.org/10.1172/jci62423
Abstract
Alarmins are endogenous molecules that are constitutively available and released upon tissue damage and activate the immune system. Current evidence indicates that uncontrolled and excessive release of alarmins contributes to the dysregulated processes seen in many inflammatory and autoimmune conditions, as well as tumorigenesis and cancer spread. Conversely, alarmins have also been found to play a major role in the orchestration of tissue homeostasis, including repair and remodeling in the heart, skin, and nervous system. Here, we provide an update and overview on alarmins, highlighting the areas that may benefit from this clinical translation.This publication has 154 references indexed in Scilit:
- High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responsesThe Journal of Experimental Medicine, 2011
- TNF-α promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cellsProceedings of the National Academy of Sciences, 2011
- High-mobility group box 1 and cancerBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010
- Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 proteinThe Journal of Experimental Medicine, 2008
- RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis modelJournal of Autoimmunity, 2007
- Functional analysis of the host defense peptide Human Beta Defensin-1: New insight into its potential role in cancerMolecular Immunology, 2007
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Proinflammatory S100 proteins in arthritis and autoimmune diseaseArthritis & Rheumatism, 2004
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001